EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities

Kyung-Hyun Cho iD, Ashutosh Bahuguna, Yunki Lee, Sang Hyuk Lee, Maria Del Carmen Dominguez-Horta, Gillian Martinez-Donato

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kyung-Hyun Cho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Raydel Research Institute, Medical Innovation Complex, Daegu 41061, Republic of Korea. Hauptthemen laut MEDLINE: Apolipoprotein A-I, Zebrafish, Antioxidants, Anti-Inflammatory Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CIGB-258, a 3 kDa peptide from heat shock protein 60, exhibits synergistic anti-inflammatory activity with apolipoprotein A-I (apoA-I) in reconstituted high-density lipoproteins (rHDLs) via stabilization of the rHDL structure. This study explored the interactions between CIGB-258 and apoA-I in the lipid-free state to assess their synergistic effects in the structural and functional enhancement of apoA-I and HDL. A co-treatment of lipid-free apoA-I and CIGB-258 inhibited the cupric ion-mediated oxidation of low-density lipoprotein (LDL) and a lowering of oxidized species in the dose-responsive manner of CIGB-258. The co-presence of CIGB-258 caused a blue shift in the wavelength of maximum fluorescence (WMF) of apoA-I with protection from proteolytic degradation. The addition of apoA-I:CIGB-258, with a molar ratio of 1:0.1, 1:0.5, and 1:1, to HDL2 and HDL3 remarkably enhanced the antioxidant ability against LDL oxidation up to two-fold higher than HDL alone. HDL-associated paraoxonase activities were elevated up to 28% by the co-addition of apoA-I and CIGB-258, which is linked to the suppression of Cu2+-mediated HDL oxidation with the slowest electromobility. Isothermal denaturation by a urea treatment showed that the co-presence of CIGB-258 attenuated the exposure of intrinsic tryptophan (Trp) and increased the mid-points of denaturation from 2.33 M for apoA-I alone to 2.57 M for an apoA-I:CIGB-258 mixture with a molar ratio of 1:0.5. The addition of CIGB-258 to apoA-I protected the carboxymethyllysine (CML)-facilitated glycation of apoA-I with the prevention of Trp exposure. A co-treatment of apoA-I and CIGB-258 synergistically safeguarded zebrafish embryos from acute death by CML-toxicity, suppressing oxidative stress and apoptosis. In adult zebrafish, the co-treatment of apoA-I+CIGB-258 exerted the highest anti-inflammatory activity with a higher recovery of swimming ability and survivability than apoA-I alone or CIGB-258 alone. A co-injection of apoA-I and CIGB-258 led to the lowest infiltration of neutrophils and interleukin (IL)-6 generation in hepatic tissue, with the lowest serum triglyceride, aspartate transaminase, and alanine transaminase levels in plasma. In conclusion, the co-presence of CIGB-258 ameliorated the beneficial functionalities of apoA-I, such as antioxidant and anti-glycation activities, by enhancing the structural stabilization and protection of apoA-I. The combination of apoA-I and CIGB-258 synergistically enforced the anti-inflammatory effect against CML toxicity in embryos and adult zebrafish.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein A-IZebrafishAntioxidantsAnti-Inflammatory AgentsLipoproteins, HDLAnimalsLipoproteins, LDLOxidation-ReductionDrug Synergism

Stichwörter der Autor:innen

CIGB-258 (Jusvinza®)apolipoprotein A-I (apoA-I)carboxymethyllysine (CML)high-density lipoproteins (HDLs)interleukin-6zebrafish

Substanzen

Apolipoprotein A-IAntioxidantsAnti-Inflammatory AgentsLipoproteins, HDLLipoproteins, LDL

Autor:innen und Institutionen

  • Raydel Research Institute, Medical Innovation Complex, Daegu 41061, Republic of Korea.
  • Center for Genetic Engineering and Biotechnology, Ave 31, e/158 y 190, Playa, La Havana 10600, Cuba.

ORCID-Profile: Kyung-Hyun Cho

Zitieren

APA

Cho, K. H., Bahuguna, A., Lee, Y., Lee, S. H., Dominguez-Horta, M. D. C., & Martinez-Donato, G. (2024). Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105560

Vancouver

Cho KH, Bahuguna A, Lee Y, Lee SH, Dominguez-Horta MDC, Martinez-Donato G. Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105560

BibTeX
@article{Cho2024,
  author = {Cho, Kyung-Hyun and Bahuguna, Ashutosh and Lee, Yunki and Lee, Sang Hyuk and Dominguez-Horta, Maria Del Carmen and Martinez-Donato, Gillian},
  title = {Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105560}
}
Kostenlos starten →